For: | Bastos JCS, Padilla MA, Caserta LC, Miotto N, Vigani AG, Arns CW. Hepatitis C virus: Promising discoveries and new treatments. World J Gastroenterol 2016; 22(28): 6393-6401 [PMID: 27605875 DOI: 10.3748/wjg.v22.i28.6393] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i28/6393.htm |
Number | Citing Articles |
1 |
Shihang Zhou, Ming Liu, Yuexin Xia, Li Zhang, Linnan Shao, Ni Wang, Weijian Yu, Nan Ding, Kaili Zhang, Xiaohua Liang. Association of the 3′ untranslated region polymorphisms of HLA-G with susceptibility to chronic hepatitis C virus infection in the Chinese population. Human Immunology 2022; 83(1): 47 doi: 10.1016/j.humimm.2021.09.001
|
2 |
Chun Zhang, Xi Yang, Quan Qi, Yuhai Gao, Qiang Wei, Shuwen Han. lncRNA-HEIH in serum and exosomes as a potential biomarker in the HCV-related hepatocellular carcinoma. Cancer Biomarkers 2018; 21(3): 651 doi: 10.3233/CBM-170727
|
3 |
Ernest Asante-Appiah, Paul Ingravallo, Patricia McMonagle, Karin Bystol, Ellen Xia, Stephanie Curry, Ping Qiu, Stuart Black, Robert Chase, Rong Liu, Fred Lahser. Interplay of Amino Acid Residues at Positions 28 and 31 in NS5A Defines Resistance Pathways in Hepatitis C Virus Genotype 2. Antimicrobial Agents and Chemotherapy 2019; 63(12) doi: 10.1128/AAC.01269-19
|
4 |
Jaydev Jangiti, Charit Gupta Paluri, Sumedha Vadlamani, Sumit Kumar Jindal. Hepatitis C Severity Prognosis: A Machine Learning Approach. Journal of Electrical Engineering & Technology 2023; 18(4): 3253 doi: 10.1007/s42835-023-01441-y
|
5 |
Ernest Asante-Appiah, Stephanie Curry, Patricia McMonagle, Paul Ingravallo, Robert Chase, David Nickle, Ping Qiu, Anita Howe, Frederick C. Lahser. Antiviral Activity and Resistance Analysis of NS3/4A Protease Inhibitor Grazoprevir and NS5A Inhibitor Elbasvir in Hepatitis C Virus GT4 Replicons. Antimicrobial Agents and Chemotherapy 2017; 61(7) doi: 10.1128/AAC.00363-17
|
6 |
Pavlina Dzekova-Vidimliski, Aleksandar Sikole. Hepatitis C Virus Infection in Maintenance Hemodialysis Patients: Recommendations for Diagnostics and Treatment. The International Journal of Artificial Organs 2016; 39(12): 590 doi: 10.5301/ijao.5000548
|
7 |
Shivani Chauhan, Keerti Jain, Saba Naqvi. Nanotheranostics for Treatment and Diagnosis of Infectious Diseases. 2022; : 199 doi: 10.1016/B978-0-323-91201-3.00004-9
|
8 |
Jack Tsai, Vera Yakovchenko, Natalie Jones, Avy Skolnik, Amanda Noska, Allen L. Gifford, D. Keith McInnes. “Where’s My Choice?” An Examination of Veteran and Provider Experiences With Hepatitis C Treatment Through the Veteran Affairs Choice Program. Medical Care 2017; 55(Suppl 1): S13 doi: 10.1097/MLR.0000000000000706
|
9 |
Reza Taherkhani, Fatemeh Farshadpour. Lurking epidemic of hepatitis C virus infection in Iran: A call to action. World Journal of Hepatology 2017; 9(24): 1040-1042 doi: 10.4254/wjh.v9.i24.1040
|
10 |
Asad Zia, Sumra Wajid Abbasi, Shabeer Ahmad, Muhammad Zia, Abida Raza. Phylogenetic analysis, structure modeling and docking study of HCV NS3 protease for the identification of potent inhibitors. Infection, Genetics and Evolution 2018; 59: 51 doi: 10.1016/j.meegid.2018.01.026
|
11 |
Vedha Sanghi, Carlos Romero-Marrero, Gianina Flocco, Rondell P. Graham, Baraa Abduljawad, Fadi Niyazi, Mohammad M. Asfari, Koji Hashimoto, Bijan Eghtesad, K. V. Narayanan Menon, Federico N. Aucejo, Rocio Lopez, Lisa M. Yerian, Daniela S. Allende. The spectrum of histopathological findings after SVR to DAA for recurrent HCV infection in liver transplant recipients. Virchows Archiv 2022; 480(2): 335 doi: 10.1007/s00428-021-03191-6
|
12 |
Yi-Hang Wu, Yan Chen, An-Qi Zhuang, Shan-Mei Chen. Antiviral Strategies in the Treatment of Human and Animal Viral Infections. Infectious Diseases 2023; 27 doi: 10.5772/intechopen.112221
|
13 |
Shihang Zhou, Xiaohua Liang, Ni Wang, Linnan Shao, Weijian Yu, Nan Ding, Kaili Zhang, Ming Liu. Association of human platelet antigens polymorphisms with the levels of serum fibrosis marks in chronic hepatitis C patients. Transfusion and Apheresis Science 2021; 60(1): 102967 doi: 10.1016/j.transci.2020.102967
|
14 |
Naoyoshi Maeda, Katsumi Maenaka. The Roles of Matricellular Proteins in Oncogenic Virus-Induced Cancers and Their Potential Utilities as Therapeutic Targets. International Journal of Molecular Sciences 2017; 18(10): 2198 doi: 10.3390/ijms18102198
|
15 |
Suyun Jeong, Young-seok Lee, Kiyoon Kim, Ji-su Yoon, Sungsoo Kim, Joohun Ha, Insug Kang, Wonchae Choe. 2-O-Methylhonokiol Suppresses HCV Replication via TRAF6-Mediated NF-kB Activation. International Journal of Molecular Sciences 2021; 22(12): 6499 doi: 10.3390/ijms22126499
|
16 |
Shahina Mumtaz, Jawad Ahmed, Amina Gul, Shafiq Ahmed Tariq, Sami Siraj, Tahir Sarwar. Genetic Diversity of Hepatitis C Virus Genotype 3a Based on Complete Core Protein in Peshawar, Pakistan. Jundishapur Journal of Microbiology 2020; 13(3) doi: 10.5812/jjm.98942
|
17 |
Saade Abdalkareem Jasim, Najwa Shihab Ahmed, Adel A. Mousa, Ahmed A. Hmed, Ahmed R. Sofy. Correlation between both genetic polymorphism and serum level of toll-like receptor 4 with viral load and genotype of hepatitis C virus in Iraqi patients. Gene Reports 2021; 24: 101287 doi: 10.1016/j.genrep.2021.101287
|
18 |
Noor Sultan, Ayub Alam, Batool Fatima, Sameera Shafi, Dilshad Hussain, Zohaib Sarwar, Muhammad Wasim, Saadat Majeed, Ahmad Yar, Muhammad Najam-ul-Haq. Fabrication of a Co-Ni/TiO2 Core-Shell Sensor for Label-Free Quantification of Human Serum Albumin in Hepatitis C Virus Patients. Journal of The Electrochemical Society 2023; 170(9): 097508 doi: 10.1149/1945-7111/acfb3e
|